848 related articles for article (PubMed ID: 26373573)
1. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
Corrales L; Gajewski TF
Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
[TBL] [Abstract][Full Text] [Related]
2. STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Demaria O; De Gassart A; Coso S; Gestermann N; Di Domizio J; Flatz L; Gaide O; Michielin O; Hwu P; Petrova TV; Martinon F; Modlin RL; Speiser DE; Gilliet M
Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15408-13. PubMed ID: 26607445
[TBL] [Abstract][Full Text] [Related]
3. cGAS-STING signaling in cancer immunity and immunotherapy.
Du H; Xu T; Cui M
Biomed Pharmacother; 2021 Jan; 133():110972. PubMed ID: 33254021
[TBL] [Abstract][Full Text] [Related]
4. The analog of cGAMP, c-di-AMP, activates STING mediated cell death pathway in estrogen-receptor negative breast cancer cells.
Vasiyani H; Shinde A; Roy M; Mane M; Singh K; Singh J; Gohel D; Currim F; Vaidya K; Chhabria M; Singh R
Apoptosis; 2021 Jun; 26(5-6):293-306. PubMed ID: 33840002
[TBL] [Abstract][Full Text] [Related]
5. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
[TBL] [Abstract][Full Text] [Related]
6. Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages?
Ohkuri T; Kosaka A; Nagato T; Kobayashi H
Hum Vaccin Immunother; 2018 Feb; 14(2):285-287. PubMed ID: 29064738
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
[TBL] [Abstract][Full Text] [Related]
9. STING: a master regulator in the cancer-immunity cycle.
Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
[TBL] [Abstract][Full Text] [Related]
10. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
11. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Mekers VE; Kho VM; Ansems M; Adema GJ
Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
[TBL] [Abstract][Full Text] [Related]
13. STING Signaling in Cancer Cells: Important or Not?
Sokolowska O; Nowis D
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
[TBL] [Abstract][Full Text] [Related]
14. Insight into the dichotomous regulation of STING activation in immunotherapy.
Hu Z; Yang Y; Fang L; Zhou J; Zhang H
Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
[TBL] [Abstract][Full Text] [Related]
15. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
[TBL] [Abstract][Full Text] [Related]
16. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
[TBL] [Abstract][Full Text] [Related]
17. STING pathway agonism as a cancer therapeutic.
Flood BA; Higgs EF; Li S; Luke JJ; Gajewski TF
Immunol Rev; 2019 Jul; 290(1):24-38. PubMed ID: 31355488
[TBL] [Abstract][Full Text] [Related]
18. cGAS-STING Activation in the Tumor Microenvironment and Its Role in Cancer Immunity.
Pépin G; Gantier MP
Adv Exp Med Biol; 2017; 1024():175-194. PubMed ID: 28921470
[TBL] [Abstract][Full Text] [Related]
19. STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment.
Ohkuri T; Ghosh A; Kosaka A; Zhu J; Ikeura M; David M; Watkins SC; Sarkar SN; Okada H
Cancer Immunol Res; 2014 Dec; 2(12):1199-208. PubMed ID: 25300859
[TBL] [Abstract][Full Text] [Related]
20. cGAS/STING Pathway in Cancer: Jekyll and Hyde Story of Cancer Immune Response.
Bose D
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]